Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 71205-144

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 71205-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Image 01)

This text seems to be a list of different medical studies or analyses along with their Hazard Ratio, Rate Ratio, or Odds Ratio results which are statistical measures related to the relative risk of experiencing a particular event or outcome among different groups. There are also indications of study type, such as Cohort or Case-Control studies, and references to different countries or entities such as the FDA and PharMetrics. The final part of the text contains a mix of numbers which is not clear how they relate to the rest of the information.*

FDA Label Image

Fig 2 (Image 02)

This is a chart showing the ranges of blood clot occurrences in women who are not pregnant, using different types of contraception (COC stands for combined oral contraceptives). The chart also shows the number of women with a blood clot out of 10,000 women years for pregnant and postpartum women within a 12 week period. The pregnancy data is based on actual pregnancy duration in reference studies and there is a model assumption that the pregnancy duration is nine months. The rate for blood clot occurrences during pregnancy is 7 to 27 per 10,000 WY.*

FDA Label Image

Drospirenone Usp Structure (Image 03)

FDA Label Image

Ethinyl Estradiol Usp Structure (Image 04)

FDA Label Image

71205-144-28 (Image 05)

This is a package of Drospirenone 3mg/ Ethinyl Estradiol 0.02mg, containing 28 day tablets. It is labeled under NDC 71205-144-28 and relabeled by Proficient Rx LP. The manufacturer is Greenmark Pharmaceuticals Ltd located in Goa, India. It has a Lot # of 00000 and SN# MASTER. Store the medication at 20°C-25°C (68°F-77°F) and out of reach of children. For more information, see the package insert.*

FDA Label Image

Blister (Image 07)

FDA Label Image

Likelihood Of Developing A Serious Blood Blot (Image 08)

This text provides information on the ranges for non-pregnant and postpartum women, as well as the number of women with a blood clot per 10,000 women years. There is also a note stating that the pregnancy data is based on the actual duration and the model assumption of nine months. The rate of blood clot for pregnancy is provided as 7 to 27 per 10,000 women years.*

FDA Label Image

Logo (Logo)

This text only includes a single word, "glenmark", which is likely a company or brand name. Without further context, it is not possible to provide a description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.